Dr. Malhotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
506 Malcolm X Blvd
New York, NY 10037
Summary
- Dr. Manoj Malhotra is a neurologist in New York, NY and is affiliated with NYC Health + Hospitals / Harlem. He received his medical degree from Wayne State University School of Medicine and has been in practice 21 years. He specializes in neurophysiology, sleep medicine, spinal disorder, and vascular neurology and is experienced in amyloid neuropathy, sleep medicine, electromyography, interventional neuroradiology / endovascular neurosurgery, and cerebrovascular disease. He has more than 20 publications and over 200 citings.
Education & Training
- Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2000 - 2001
- Cleveland Clinic FoundationResidency, Neurology, 1997 - 2000
- Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1996 - 1997
- Wayne State University School of MedicineClass of 1996
Certifications & Licensure
- MI State Medical License 2014 - 2027
- NY State Medical License 2008 - 2026
- OH State Medical License 1998 - 2026
- CA State Medical License 2013 - 2025
- NJ State Medical License 2008 - 2025
- IL State Medical License 2012 - 2017
- WI State Medical License 2012 - 2017
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
- American Board of Psychiatry and Neurology Sleep Medicine
- American Board of Psychiatry and Neurology Vascular Neurology
Publications & Presentations
PubMed
- 1 citationsEfficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.Valerie Arnold, Sonia Ancoli-Israel, Thien Thanh Dang-Vu, Kazuo Mishima, Kate Pinner
Neurology and Therapy. 2024-08-01 - Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.Vineet Punia, Pavel Klein, Temenuzhka Mihaylova, Victor Biton, Omar Samad
Journal of Neurology. 2024-07-01 - Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Stud...Sangeeta Ravat, Anshu Rohatgi, Rahul Kulkarni, Shaik A Jabeen, Balaji Patil
Epilepsia Open. 2024-06-01
Press Mentions
- Lower Hospitalization Rates in Epilepsy Patients Treated with Adjunctive FYCOMPA® (Perampanel) CIIIMay 9th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: